HBP Share Price

Open 0.90 Change Price %
High 0.90 1 Day -0.03 -3.23
Low 0.90 1 Week 0.00 0.00
Close 0.90 1 Month -0.05 -5.26
Volume 14000 1 Year -1.10 -55.00
52 Week High 2.00
52 Week Low 0.70
HBP Important Levels
Resistance 2 0.90
Resistance 1 0.90
Pivot 0.90
Support 1 0.90
Support 2 0.90
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
TCW 3.59 1.41%
TCW 3.59 1.41%
ECA 12.96 4.35%
ECA 12.96 4.35%
More..
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
CCZ 0.17 21.43%
DNT 0.07 16.67%
CUM 0.90 13.92%
CUM 0.90 13.92%
More..
TSE Canada Top Losers Stocks
LRT-UN 0.02 -50.00%
GBV 0.46 -24.59%
CTU-A 0.19 -9.52%
BAA 0.60 -7.69%
BAA 0.60 -7.69%
DEJ 0.14 -6.67%
DEJ 0.14 -6.67%
FRC 6.66 -6.06%
FRC 6.66 -6.06%
NHC 2.86 -5.30%
More..

Helix BioPharma Corp (TSE: HBP)

HBP Technical Analysis 4
As on 25th Jul 2017 HBP Share Price closed @ 0.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.56 & Sell for SHORT-TERM with Stoploss of 0.99 we also expect STOCK to react on Following IMPORTANT LEVELS.
HBP Target for July
1st Target up-side 1
2nd Target up-side 1.04
3rd Target up-side 1.08
1st Target down-side 0.9
2nd Target down-side 0.86
3rd Target down-side 0.82
HBP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.helixbiopharma.com
HBP Address
HBP
305 Industrial Parkway South
Unit 3
Aurora, ON L4G 6X7
Canada
Phone: 905-841-2300
Fax: 905-841-2244
HBP Latest News
Helix BioPharma Corp. Initiates Enrollment in the Third Dosing Cohort of US ...   Marketwired (press release)   - 26th Jul 17
Placing the Spotlight on Helix Biopharma Corp (HBP.TO): Technical Stock Update   Evergreen Caller   - 25th Jul 17
Helix Biopharma Corp (HBP.TO) Money Flow Index Levels in Focus   The Times   - 25th Jul 17
Helix BioPharma Corp. Announces Collaboration with Moffitt Cancer Center   Marketwired (press release)   - 11th Jul 17
Helix BioPharma Corp. Announces Fiscal Third Quarter 2017 Results   Marketwired (press release)   - 14th Jun 17
Helix BioPharma Corp. Subsidiary, Helix Polska Sp. z oo, Finalizes Grant ...   Marketwired (press release)   - 22nd Jul 16
Helix BioPharma Corp. Announces Agreement in Principle With National Research ...   Marketwired (press release)   - 19th Jul 16
Helix BioPharma Corp. Opens the Market   Canada NewsWire (press release)   - 26th May 16
Helix BioPharma Corp. Announces CEO Change   Marketwired (press release)   - 30th Mar 16
0.666   MarketWatch   - 22nd May 13
Interactive Technical Analysis Chart Helix BioPharma Corp ( HBP TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Helix BioPharma Corp
HBP Business Profile
Helix BioPharma Corp., a biopharmaceutical company, develops drugs for the prevention and treatment of cancer based on its proprietary technologies. The company focuses on the development of L-DOS47 that is in phase I/II clinical trial for the treatment of inoperable, locally advanced, and recurrent or metastatic non-small cell lung cancer; and Topical Interferon Alpha-2b, which has completed phase II study for the treatment of low-grade cervical lesions and ano-genital warts caused by human papilloma virus infections. It also offers DOS47, a patented oncology platform technology that derives a therapeutic pharmacological effect by acting upon a naturally occurring substance in the body. Helix BioPharma Corp. is based in Aurora, Canada.